{
    "2021-06-03": [
        [
            {
                "time": "",
                "original_text": "拜耳集团大中华区总裁，辞职",
                "features": {
                    "keywords": [
                        "拜耳集团",
                        "大中华区",
                        "总裁",
                        "辞职"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "73名药企高管，宣布辞职",
                "features": {
                    "keywords": [
                        "药企",
                        "高管",
                        "辞职",
                        "73名"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-06-03",
                "original_text": "6月3日晚间重要行业研究汇总(附股)",
                "features": {
                    "keywords": [
                        "行业研究",
                        "汇总",
                        "附股",
                        "6月3日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国信证券：医药板块调整后延续反弹态势，回归均衡风格",
                "features": {
                    "keywords": [
                        "国信证券",
                        "医药板块",
                        "调整",
                        "反弹",
                        "均衡风格"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06",
                "original_text": "医药生物2021年6月策略：不忘疫情防控，重视创新与消费升级",
                "features": {
                    "keywords": [
                        "医药生物",
                        "策略",
                        "疫情防控",
                        "创新",
                        "消费升级",
                        "2021年6月"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}